Gemma G. Kenter

Gemma G. Kenter publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gemma G. Kenter sits on this spectrum.

Gemma G. Kenter D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gemma G. Kenter sits on this spectrum.

Overview

Best Publications

• Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

  Ignace Vergote;Claes G. Tropé;Frédéric Amant;Gunnar B. Kristensen

  2598
  Citations

• Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

  Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  1310
  Citations

• Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

  Dorien C Rijkaart;Johannes Berkhof;Lawrence Rozendaal;Folkert J van Kemenade

  649
  Citations

• Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

  Wouter Scheper;Sander Kelderman;Lorenzo F. Fanchi;Carsten Linnemann

  577
  Citations

• Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

  Yvonne M C Hendriks;Anja Wagner;Hans Morreau;Fred Menko

  514
  Citations

• High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

  Sytse J. Piersma;Ekaterina S. Jordanova;Mariëtte I.E. van Poelgeest;Kitty M.C. Kwappenberg

  497
  Citations

• Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

  Marij J P Welters;Gemma G Kenter;Sytse J Piersma;Annelies P G Vloon

  482
  Citations

• Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity

  Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  426
  Citations

• Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

  Annemieke de Jong;Mariëtte I. E. van Poelgeest;Jeanette M. van der Hulst;Jan Wouter Drijfhout

  403
  Citations

• Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions

  K. N. Gaarenstroom;G. G. Kenter;J. B. Trimbos;I. Agous

  393
  Citations

• Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

  Marij J. P. Welters;Gemma G. Kenter;Peggy J. de Vos van Steenwijk;Margriet J. G. Löwik

  336
  Citations

• Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

  Rezaul Karim;Ekaterina S. Jordanova;Sytse J. Piersma;Gemma G. Kenter

  315
  Citations

• Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.

  Marij J. P. Welters;Annemieke de Jong;Susan J. F. van den Eeden;Jeanette M. van der Hulst

  314
  Citations

• Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens

  Sjoerd H. van der Burg;Sytse J. Piersma;Annemieke de Jong;Jeanette M. van der Hulst

  310
  Citations

• Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.

  A. Marijne Heeren;Simone Punt;Maaike C. G. Bleeker;Katja N. Gaarenstroom

  307
  Citations

• The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma

  Isis Dove-Edwin;Dominique Boks;Sheila Goff;Gemma G. Kenter

  304
  Citations

• Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

  Ekaterina S. Jordanova;Arko Gorter;Ouissam Ayachi;Frans Prins

  298
  Citations

• Vaccination with HPV16 peptides of patients with advanced cervical carcinoma : Clinical evaluation of a phase I-II trial

  W.J. van Driel;M.E. Ressing;G.G. Kenter;R.M.P. Brandt

  288
  Citations

• A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients.

  J. B. Trimbos;C. P. Maas;M. C. Deruiter;A. A. W. Peters

  268
  Citations

• Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

  Wiljo J. F. de Leeuw;Wiljo J. F. de Leeuw;JanWillem Dierssen;Hans F. A. Vasen;Juul Th. Wijnen

  263
  Citations